feed,title,long_url,short_url
Investors,"Cogent Biosciences Hits 7-Year High, Up 120% On Its New Stomach Cancer Promise",https://www.investors.com/news/technology/cogent-biosciences-stock-gist-treatment/,
Investors,Why Gene-Editing Giants Crispr And Intellia Just Surged,https://www.investors.com/news/technology/crispr-stock-intellia-stock-gene-editing-cholesterol-triglycerides-hae/,
